600例微创胰肝切除中从腹腔镜转向机器人手术的影响
单中心回顾性分析2010年1月至2022年2月共1875例胰腺和肝脏切除,其中600例(32%)为微创胰肝切除(MIS-HPB)。机器人胰十二指肠切除术缩短手术时间和降低胃排空延迟,机器人肝切除减少总体并发症和住院时间。
要点
- 机器人手术引入后MIS-HPB使用率从25.3%升至43.8%,出血量从250ml降至150ml。
- 机器人胰十二指肠切除术手术时间缩短(450 vs 361 min),胃排空延迟率降低(28.8% vs 9.9%)。
- 机器人肝切除总体并发症减少(24.7% vs 10.8%),住院时间缩短(4 vs 3天)。
核心结论
- 机器人手术的引入与MIS-HPB实施率提高至近半数胰腺和肝脏切除相关,虽未影响死亡率和主要并发症,但改善了部分选定结局。
主要发现
- 600例MIS-HPB中,总体中转率4.3%,Clavien-Dindo≥3并发症25.7%,院内/30天死亡率1.8%(n=11)。
- 机器人胰十二指肠切除术与手术时间缩短(450 vs 361 min;P<0.001)、出血量减少(350 vs 200 ml;P<0.001)和胃排空延迟率降低(28.8% vs 9.9%;P=0.009)相关。
- 机器人肝切除与总体并发症减少(24.7% vs 10.8%;P=0.003)和住院时间缩短(4 vs 3天;P<0.001)相关。
临床怎么用
- 在高流量中心,经专门培训后从腹腔镜转向机器人MIS-HPB是安全可行的,可提高微创实施率并改善部分围术期结局。
局限性
- 单中心回顾性研究,非随机设计,机器人手术的附加价值尚需随机研究和高质量注册数据确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many centers worldwide are shifting from laparoscopic to robotic minimally invasive hepato-pancreato-biliary resections (MIS-HPB) but large single center series assessing this process are lacking. We hypothesized that the introduction of robot-assisted surgery was safe and feasible in a high-volume center. METHODS: Single center, post-hoc assessment of prospectively collected data including all consecutive MIS-HPB resections (January 2010-February 2022). As of December 2018, all MIS pancreatoduodenectomy and liver resections were robot-assisted. All surgeons had participated in dedicated training programs for laparoscopic and robotic MIS-HPB. Primary outcomes were in-hospital/30-day mortality and Clavien-Dindo ≥ 3 complications. RESULTS: Among 1875 pancreatic and liver resections, 600 (32%) were MIS-HPB resections. The overall rate of conversion was 4.3%, Clavien-Dindo ≥ 3 complications 25.7%, and in-hospital/30-day mortality 1.8% (n = 11). When comparing the period before and after the introduction of robotic MIS-HPB (Dec 2018), the overall use of MIS-HPB increased from 25.3 to 43.8% (P < 0.001) and blood loss decreased from 250 ml [IQR 100-500] to 150 ml [IQR 50-300] (P < 0.001). The 291 MIS pancreatic resections included 163 MIS pancreatoduodenectomies (52 laparoscopic, 111 robotic) with 4.3% conversion rate. The implementation of robotic pancreatoduodenectomy was associated with reduced operation time (450 vs 361 min; P < 0.001), reduced blood loss (350 vs 200 ml; P < 0.001), and a decreased rate of delayed gastric emptying (28.8% vs 9.9%; P = 0.009). The 309 MIS liver resections included 198 laparoscopic and 111 robotic procedures with a 3.6% conversion rate. The implementation of robotic liver resection was associated with less overall complications (24.7% vs 10.8%; P = 0.003) and shorter hospital stay (4 vs 3 days; P < 0.001). CONCLUSION: The introduction of robotic surgery was associated with greater implementation of MIS-HPB in up to nearly half of all pancreatic and liver resections. Although mortality and major morbidity were not affected, robotic surgery was associated with improvements in some selected outcomes. Ultimately, randomized studies and high-quality registries should determine its added value.
引用
- Emmen AMLH, Görgec B, Zwart MJW, et al. Impact of shifting from laparoscopic to robotic surgery during 600 minimally invasive pancreatic and liver resections. Surg Endosc. 2022. PMID: 36401105. doi:10.1007/s00464-022-09735-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。